Apollon Papadimitriou
Vorstandsvorsitzender bei iOmx Therapeutics AG
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Patrick Baeuerle | M | 66 |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 8 Jahre |
| Henrijette Richter | M | 53 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | - |
| Philipp Beckhove | M | - |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 8 Jahre |
| Gerald Heinz Möller | M | 80 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 4 Jahre |
| Rainer Strohmenger | M | 57 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 4 Jahre |
| Matthias Kromayer | M | 58 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 2 Jahre |
| Michael Burgess | M | 61 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 2 Jahre |
| Rainer Kramer | M | 60 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Joachim Kuhn | M | 60 |
Julius-Maximilians-Universität Würzburg
| 9 Jahre |
| Dirk Altenbeck | M | 59 |
Julius-Maximilians-Universität Würzburg
| 7 Jahre |
| Anthony Adam Rosenberg | M | 71 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | - |
| Holger-Michael Wagner | M | - |
Julius-Maximilians-Universität Würzburg
| 6 Jahre |
| Alexander Thees | M | - |
Julius-Maximilians-Universität Würzburg
| 5 Jahre |
| Christopher Kessler | M | 61 |
Julius-Maximilians-Universität Würzburg
| 9 Jahre |
| Martin Simon | M | 57 |
Julius-Maximilians-Universität Würzburg
| 6 Jahre |
| Björn H. Söder | M | 52 |
Julius-Maximilians-Universität Würzburg
| 4 Jahre |
| Philip Grosse | M | 53 |
Julius-Maximilians-Universität Würzburg
| 4 Jahre |
| Gunther Schunk | M | 57 |
Julius-Maximilians-Universität Würzburg
| - |
| Shinichiro Fuse | M | - |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | - |
| Marco Brockhaus | M | 56 |
Julius-Maximilians-Universität Würzburg
| 4 Jahre |
| Tao Wang | M | - |
Julius-Maximilians-Universität Würzburg
| 3 Jahre |
| Christoph Schäfers | M | 58 |
Julius-Maximilians-Universität Würzburg
| 2 Jahre |
| Frank Hensel | M | - |
Julius-Maximilians-Universität Würzburg
| 3 Jahre |
| Daniel Vitt | M | 55 |
Julius-Maximilians-Universität Würzburg
| 3 Jahre |
| Heiko Roman Michael Fischer | M | 56 |
Julius-Maximilians-Universität Würzburg
| 3 Jahre |
| Steven St. Peter | M | 57 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | 1 Jahre |
| Caroline Toffel | M | 54 |
Julius-Maximilians-Universität Würzburg
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Deutschland | 27 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Apollon Papadimitriou
- Persönliches Netzwerk